Abstract
The purpose of this TriMark Publications report is to describe the specific
market segment of the in vitro diagnostics market called point of care testing
(POCT). It examines these clinical measurement devices and their reagents and
supplies as utilized in hospitals, clinics and doctor' s offices. An analysis
of analytes that are related to the common chemical constituents of blood,
plasma or serum at the point of care of the patient is addressed. Moreover,
the study defines the dollar volume of sales, both worldwide and in the U.S.,
and analyzes the factors that influence the size and the growth of the market
segments. Also examined are the subsections of each market segment, including
the research labs, hospital labs and commercial laboratories. Additionally,
rapid detection of food pathogens and infectious pathogens (MRSA, herpes
simplex, avian flu, West Nile virus and typhoid) are discussed. The report
surveys almost all of the companies known to be marketing, manufacturing or
developing instruments and reagents for the point of care market in the U.S.
Each company is discussed in extensive depth with a section on its history,
product line, business and marketing analysis, and a subjective commentary of
the company' s market position.
View Cart
